[1] HINCHEY J，CHAVES C，APPIGNANI B，et

al. A reversible posterior leukoencephalopathy

syndrome[J]. N Engl J Med，1996，334（8)：494.

[2] WANG W，ZHAO L R，LIN X Q，et al. Reversible

posterior leukoencephalopathy syndrome induced by

bevacizumab plus chemotherapy in colorectal cancer[J].

World J Gastroenterol，2014，20（21)：6691-6697.

[3] KIM C A，PRICE-HILLER J，CHU Q S，et al.

Atypical reversible posterior leukoencephalopathy

syndrome（RPLS）induced by cediranib in a patient

with metastatic rectal cancer[J]. Invest New Drugs，

2014，32（5)：1036-1045.

[4] COSTA RICARDO, COSTA RUBENS, COSTA

RENATA，et al. Reversible posterior encephalopathy

syndrome secondary to sunitinib[J/OL]. Case

Rep Oncol Med，2014，2014：952624. https：//doi.

org/10.1155/2014/952624.

[5] FOERSTER R，WELZEL T，DEBUS J，et al.

Posterior reversible leukoencephalopathy syndrome

associated with pazopanib[J]. Case Rep Oncol，2013，

6（1)：204-208.

[6] KAGER L M，KERSTEN M J，KLOPPENBORG

R P，et al. Reversible posterior leucoencephalopathy

syndrome associated with bortezomib in a patient

with relapsed multiple myeloma[J/OL]. BMJ Case

Rep，2009，2009. pii：bcr06. 2009. 1926. https：//doi.

org/10.1136/bcr.06.2009.1926.

[7] MIZUTANI M，NAKAMORI Y，SAKAGUCHI H，et

al. Development of syndrome of inappropriate secretion

of ADH and reversible posterior leukoencephalopathy

during initial rituximab-CHOP therapy in a patient

with diffuse large B-cell lymphoma[J]. Rinsho Ketsueki，

2013，54（3)：269-272.

[8] KHURANA A，DASANU C A. Posterior reversible

encephalopathy syndrome due to targeted agents：

vemurafinib among suspects![J]. J Oncol Pharm

Pract，2015，85（11)：443-450.

[9] KANEDA H，OKAMOTO I，SATOH T，et al.

Reversible posterior leukoencephalopathy syndrome

and trastuzumab[J]. Invest New Drugs，2012，30（4)：

1766-1767.

[10] MYINT Z W，SEN J M，WATTS N L，et

al. Reversible Posterior Leukoencephalopathy

Syndrome During Regorafenib Treatment：A Case

Report and Literature Review of Reversible Posterior

Leukoencephalopathy Syndrome Associated With

Multikinase Inhibitors[J]. Clin Colorectal Cancer，

2014，13（2)：127-130.

[11] ZHANG H. Apatinib for molecular targeted therapy

in tumor[J/OL]. Drug Des Devel Ther，2015，9：

6075-6081. https：//doi. org/10. 2147/DDDT. S97235.